Trials / Completed
CompletedNCT03402087
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
An Open-Label, Single-Sequence Study to Investigate the Effects of BMS-986165 on the Single-Dose Pharmacokinetics of Methotrexate in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate effects of BMS-986165 on blood levels of methotrexate given as a single dose in healthy male patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methotrexate | Specified dose on specified days |
| DRUG | Leucovorin | Specified dose on specified days |
| DRUG | BMS-986165 | Specified dose on specified days |
Timeline
- Start date
- 2018-01-08
- Primary completion
- 2018-03-20
- Completion
- 2018-03-25
- First posted
- 2018-01-18
- Last updated
- 2020-02-25
Locations
1 site across 1 country: Netherlands
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03402087. Inclusion in this directory is not an endorsement.